Literature DB >> 17000036

Monitoring temperatures in the vaccine cold chain in Bolivia.

Carib Nelson1, Paulo Froes, Anne Mie Van Dyck, Jeaneth Chavarría, Enrique Boda, Alberto Coca, Gladys Crespo, Heinz Lima.   

Abstract

This study monitored vaccine cold chain temperatures during routine DTP-HB-Hib vaccine shipments from central stores to 11 communities in 3 provinces of Bolivia. In all 11 monitored shipments, vaccines were exposed to freezing temperatures at one or more points. In each of the shipments, temperatures below 0 degrees C were recorded for 2-50% of the monitoring period. Freezing occurred at almost every level of the cold chain distribution system, especially during district and health center storage and during transport to the province and district levels. Seven of the 11 shipments were exposed to temperatures above 8 degrees C, although none were exposed to excessive heat longer than 1.3% of the total monitoring period.

Mesh:

Substances:

Year:  2006        PMID: 17000036     DOI: 10.1016/j.vaccine.2006.08.017

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.

Authors:  Manoj V Murhekar; Srihari Dutta; Ambujam Nair Kapoor; Sailaja Bitragunta; Raja Dodum; Pramit Ghosh; Karumanagounder Kolanda Swamy; Kalyanranjan Mukhopadhyay; Somorjit Ningombam; Kamlesh Parmar; Devegowda Ravishankar; Balraj Singh; Varsha Singh; Rajesh Sisodiya; Ramaratnam Subramanian; Tana Takum
Journal:  Bull World Health Organ       Date:  2013-09-09       Impact factor: 9.408

2.  Evaluation of an outside-the-cold-chain vaccine delivery strategy in remote regions of western China.

Authors:  Qian Ren; Hongyan Xiong; Yafei Li; Rufu Xu; Caizhong Zhu
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

3.  Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.

Authors:  Osman David Mansoor; Debra Kristensen; Andrew Meek; Simona Zipursky; Olga Popova; Olga Popovaa; InderJit Sharma; Gisele Miranda; Jules Millogo; Heidi Lasher
Journal:  Bull World Health Organ       Date:  2012-11-05       Impact factor: 9.408

4.  Evaluation of the availability of cold chain tools and an assessment of health workers practice in dammam.

Authors:  Kholood M Mugharbel; Safa M Al Wakeel
Journal:  J Family Community Med       Date:  2009-09

5.  Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.

Authors:  Pat Lennon; Brian Atuhaire; Shahrzad Yavari; Vidya Sampath; Mercy Mvundura; Nithya Ramanathan; Joanie Robertson
Journal:  Vaccine       Date:  2017-04-19       Impact factor: 3.641

6.  Molecular basis for the thermostability of Newcastle disease virus.

Authors:  Guoyuan Wen; Xiao Hu; Kang Zhao; Hongling Wang; Zhenyu Zhang; Tengfei Zhang; Jinlong Yang; Qingping Luo; Rongrong Zhang; Zishu Pan; Huabin Shao; Qingzhong Yu
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

Review 7.  Tools and approaches to ensure quality of vaccines throughout the cold chain.

Authors:  Umit Kartoglu; Julie Milstien
Journal:  Expert Rev Vaccines       Date:  2014-05-28       Impact factor: 5.217

8.  Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.

Authors:  Debra D Kristensen; Tina Lorenson; Kate Bartholomew; Shirley Villadiego
Journal:  Vaccine       Date:  2016-01-08       Impact factor: 3.641

9.  Good vaccination practice: it all starts with a good vaccine storage temperature.

Authors:  Frédéric Vangroenweghe
Journal:  Porcine Health Manag       Date:  2017-12-04

10.  A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.

Authors:  Prasad S Kulkarni; Sajjad Desai; Tushar Tewari; Anand Kawade; Nidhi Goyal; Bishan Swarup Garg; Dinesh Kumar; Suman Kanungo; Veena Kamat; Gagandeep Kang; Ashish Bavdekar; Sudhir Babji; Sanjay Juvekar; Byomkesh Manna; Shanta Dutta; Rama Angurana; Deepika Dewan; Abhijeet Dharmadhikari; Jagdish K Zade; Rajeev M Dhere; Alan Fix; Maureen Power; Vidyasagar Uprety; Varsha Parulekar; Iksung Cho; Temsunaro R Chandola; Vikash K Kedia; Abhishek Raut; Jorge Flores
Journal:  Vaccine       Date:  2017-09-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.